|

Efineptakin alfa Clinical Trials

1 actively recruiting trial across 1 location

Also known as: GX-I7, Hyleukin-7 (TM), IL-7-hyFc, Il-7 Hybrid Fc, NT-I7, TJ 107, TJ-107, TJ107, rhIL-7-hyFc

Rochester, Minnesota1 trial

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Mayo Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.